Posted in | News | Laser

Lockheed Martin Receives $24.2 Million U.S. Navy Contract to Produce Enhanced Laser Guided Training Rounds

Lockheed Martin received $24.2 million in contracts from the U.S. Navy to produce Enhanced Laser Guided Training Rounds (ELGTR), a cost-effective alternative to using operational laser-guided bombs (LGB) during training.

ELGTR emulates the flight characteristics of PavewayTM II laser-guided weapon systems and presents pilots with the same information they would see in an actual mission.

"ELGTR is the most cost-effective and reliable live-fire direct attack training solution that allows users to conserve tactical weapon inventory," said Joe Serra, precision guided systems manager at Lockheed Martin Missiles and Fire Control. "U.S. and allied warfighters continue to rely on ELGTR to maintain combat readiness against challenging operational target engagements."

The award represents the third order under the 2013 ELGTR contract. As part of the contract, Lockheed Martin will deliver ELGTRs and associated technical data, as well as refurbish U.S. government shipping containers.

Lockheed Martin has produced more than 140,000 advanced training rounds for the U.S. Navy, Marine Corps and international customers since LGTR production began in 1992. Recognized worldwide as the only live-fire LGB training solution for warfighters, the ELGTR is compatible with F/A-18, AV-8B, F-16 and various international aircraft platforms.

In addition to ELGTR, Lockheed Martin's 350,000-square-foot production facility in northeastern Pennsylvania designs and manufactures combat-proven Paveway II Plus LGB kits. The company has delivered training rounds, more than 70,000 LGB kits and 7,000 Dual Mode LGB kits to the U.S. Navy, Marine Corps, Air Force and 20 international customers.

For additional information, visit our website: www.lockheedmartin.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.